ESC 365 - SGLT2 inhibitors for lowering cardiovascular risk: evidence and expectations

EAPC Premium Access

SGLT2 inhibitors for lowering cardiovascular risk: evidence and expectations

Session: Latest pharmacological tools in preventive cardiology

Topic: Risk Factors and Prevention

Speaker: Professor L. Ryden (Stockholm, SE)

Event: ESC Preventive Cardiology 2022

Congress Presentation

About the speaker

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)

37 presentations

1 follower

3 more presentations in this session

New kids on the block in lipid treatment: PCSK9 inhibition, bempedoic acid, nutraceuticals

Speaker: Professor K. Ray (London, GB)

Gut microbiome: how do drugs affect it?

Speaker: Doctor S. Forslund (Berlin, DE)

Discussion - Latest pharmacological tools in preventive cardiology

Access the full session

Latest pharmacological tools in preventive cardiology

Speakers: Professor L. Ryden, Professor K. Ray, Doctor S. Forslund

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

ESC 365 is supported by